Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 981 across all filing types
Latest filing 2025-11-17 M&A Activity
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
SUPPLEMENTAL ANNOUNCEMENT REGARDING THE ACQUISITION OF 82.54% INTEREST IN BIORTUS CONSTITUTING CONNECTED TRANSACTION
M&A Activity Classification · 1% confidence The document is a 'Supplemental Announcement' regarding a previously disclosed acquisition of an 82.54% interest in Biortus. It provides additional details on the valuation methodology, comparable company analysis, and the rationale for the consideration paid. Since this document relates to a merger/acquisition transaction and provides further details on the terms of that transaction, it falls under the M&A Activity category.
2025-11-17 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-11-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Stock Exchange under Listing Rule Chapter 19B, detailing movements in authorised/registered share capital, issued shares, treasury shares, and related share arrangements. It is a periodic compliance filing rather than a standalone capital raise announcement, annual report, or earnings release. No other specific category fits this type of routine regulatory update, so it is classified as a general regulatory filing (RNS).
2025-11-05 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-11-03 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-10-28 English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD
Governance Information Classification · 1% confidence The document is the “Terms of Reference of the Nomination Committee,” which sets out the composition, duties, procedures and internal rules for a board committee. It is a governance charter detailing internal corporate governance structures rather than financial results, announcements, or shareholder voting materials. Therefore, it is classified as Governance Information (CGR).
2025-10-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.